VEGF-C and VEGF-D are key mediators of tumor lymphangiogenesis and α9β1 binds to the EYP sequence in VEGF-A, C, and D to promote endothelial and tumor cell migration [25, 26]. The gene discussed is VEGFD; the disease is neoplasm.